Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
SSRIs or SNRIs vs amitriptyline Quality of life · patients for whom migraine preventive interventions are indicated Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for… (2015) · Cochrane | no estimate extracted | NR | No studies |
SSRIs or SNRIs vs placebo Quality of life · patients for whom migraine preventive interventions are indicated Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for… (2015) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic fundoplication vs medical management Adverse events · Patients with gastro‐oesophageal reflux disease (GORD) in adults Laparoscopic fundoplication surgery versus medical management for gastro‐oesophageal reflux disease (GORD)… (2015) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic fundoplication vs medical management Dysphagia · Patients with gastro‐oesophageal reflux disease (GORD) in adults Laparoscopic fundoplication surgery versus medical management for gastro‐oesophageal reflux disease (GORD)… (2015) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic fundoplication vs medical management Heartburn · Patients with gastro‐oesophageal reflux disease (GORD) in adults Laparoscopic fundoplication surgery versus medical management for gastro‐oesophageal reflux disease (GORD)… (2015) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic fundoplication vs medical management Reflux · Patients with gastro‐oesophageal reflux disease (GORD) in adults Laparoscopic fundoplication surgery versus medical management for gastro‐oesophageal reflux disease (GORD)… (2015) · Cochrane | no estimate extracted | NR | No studies |
Metronidazole vs placebo HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel Clinician's Erythema Assessment ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Doxycycline 40 mg + azelaic acid gel vs doxycycline 40 mg + metronidazole gel Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical metronidazole vs oral (oxy)tetracycline HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical metronidazole vs oral (oxy)tetracycline Time needed until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical metronidazole vs oral (oxy)tetracycline Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Low dose isotretinoin 0.3 mg/kg vs doxycycline 50‐100 mg HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Low dose isotretinoin 0.3 mg/kg vs doxycycline 50‐100 mg Time needed until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Low dose isotretinoin 0.3 mg/kg vs doxycycline 50‐100 mg Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Lesion count ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Time until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs Nd:YAG laser Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Lesion count ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Time until improvement ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Pulsed dye laser vs intense pulsed light therapy Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Azelaic acid vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs placebo Assessment of erythema or telangiectasia ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle Physician‐assessed improvement in rosacea severity ‐ not reported · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle Lesion count ‐ not reported · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical brimonidine vs vehicle Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical azelaic acid vs topical metronidazole HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical azelaic acid vs topical metronidazole Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs topical metronidazole Assessment of erythema or telangiectasia ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Topical ivermectin vs topical metronidazole Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Assessment of erythema or telangiectasia ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Lesion count ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Time needed until improvement of the skin lesions ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Ciclosporin ophthalmic emulsion 0.05% vs artificial tears Duration of remission ‐ not measured · Participants with ocular rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo Participant‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo Time needed until improvement of the skin lesions ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Tetracycline vs placebo HRQOL ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Tetracycline vs placebo Time needed until improvement of the skin lesions ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |
Tetracycline vs placebo Duration of remission ‐ not measured · Participants with rosacea Interventions for rosacea (2015) · Cochrane | no estimate extracted | NR | No studies |